z-logo
open-access-imgOpen Access
Clinical Impact of Initiation of U-500 Insulin vs Continuation of U-100 Insulin in Subjects With Diabetes
Author(s) -
Alexander Ramirez
Publication year - 2021
Publication title -
federal practitioner
Language(s) - English
Resource type - Journals
pISSN - 1078-4497
DOI - 10.12788/fp.0105
Subject(s) - medicine , insulin , hypoglycemia , diabetes mellitus , incidence (geometry) , dose , obesity , insulin resistance , endocrinology , physics , optics
The prevalence of obesity and diabetes mellitus (DM) has each increased drastically according to the Centers for Disease Control and Prevention. Growth of severe insulinresistant DM is predicted. U-500 insulin is highly concentrated and can replace less concentrated formulations in patients that need high insulin dosages. The aim of this study was to compare clinical outcomes of U-500 and U-100 insulin regimens in veterans with obesity and insulin resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here